High tetanus antitoxin antibody concentrations in the Netherlands: A seroepidemiological study

Vaccine

Volumn 28, Issue 49, 2010, Pages 7803-7809

  Steens, Anneke ^a   Mollema, L ^a   Berbers, G A M ^a   van Gageldonk, P G M ^a   van der Klis, F R ^a   de Melker, H E ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Post exposure prophylaxis guidelines; Tetanus antitoxin antibodies; Tetanus vaccination

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; TETANUS ANTIBODY; TETANUS ANTITOXIN ANTIBODY; TETANUS TOXOID; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; FEMALE; GEOMETRIC MEAN CONCENTRATION; HUMAN; IMMUNOASSAY; IMMUNOPROPHYLAXIS; INFANT; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; NETHERLANDS; PERTUSSIS; POPULATION BASED CASE CONTROL STUDY; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; RELIGION; SCHOOL CHILD; SEROEPIDEMIOLOGY; SEROPREVALENCE; TETANUS; TETANUS PROPHYLAXIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EMIGRANTS AND IMMIGRANTS; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; INFANT; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; SEROEPIDEMIOLOGIC STUDIES; TETANUS; TETANUS ANTITOXIN; TETANUS TOXOID; YOUNG ADULT;

EID: 78349307603     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.09.036     Document Type: Article

References (25)

1. van den Hof S, Conyn-Van Spaendonck MAE, De Melker HE, Geubbels ELPE, Suijkerbuijk AWM, Talsma E, et al. The effects of vaccination, the incidence of the target diseases. National Institute of Public Health and the Environment. RIVM report 213676008; 1998. p. 52.
2. Abbink F., de Greeff S.C., van den H.S., De Melker H.E. Het Rijksvaccinatieprogramma in Nederland: het voorkomen van de doelziekten (1997-2002) 2004, p. 16 [210021001/2004]. RIVM (Ed.).
3. Borrow R., Balmer P., Roper M.H. The immunological basis for immunization series. Module 3: tetanus update 2006 2006, WHO.
4. Changes in the National Immunization Program in the Netherlands; 2010 [in Dutch]. http://www.rivm.nl/rvp/geschiedenis/veranderingen_rvp/index.jsp.
5. de Greeff S.C., De Melker H.E., Spanjaard L., Schouls L.M., van Derende A. Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands. Pediatr Infect Dis J 2006, 25(1):79-80.
6. Borrow R., Findlow J. Prevention of meningococcal serogroup C disease by NeisVac-C. Expert Rev Vaccines 2009, 8(3):265-279.
7. Vaccination for travelling; 12-8-2010. http://www.vaccinatiesopreis.nl/dtp-inenting/.
8. Health Council of the Netherlands Tetanus prophylaxis in injuries 2003, Health Council of the Netherlands, The Hague, p. 11.
9. van der Klis F.R., Mollema L., Berbers G.A.M., De Melker H.E., Coutinho R.A. Second national serum bank for population-based seroprevalence studies in the Netherlands. Neth J Med 2009, 67(7):301-308.
10. De Melker H.E., Conyn-Van Spaendonck M.A. Immunosurveillance and the evaluation of national immunization programmes: a population-based approach. Epidemiol Infect 1998, 121(3):637-643.
11. Mollema L, de Melker HE, Hahné S, van Weert JWM, Berbers GAM, van der Klis FR. PIENTER 2-project: second research project on the protection against infectious diseases offered by the national immunization programme in the Netherlands RIVM; 2010 [230421001/2009].
12. Knippenberg H., Stoppelenburg C.M., Wusten H.H. De protestantenband van Nederland: de geografische spreiding der orthodox-protestanten in 1920 en 1985/86. KNAG Geografisch Tijdschrift 1986, 23:12-22.
13. van Gageldonk P.G., van Schaijk F.G., van der Klis F.R., Berbers G.A. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus. J Immunol Methods 2008, 335(1-2):79-89.
14. Hendriksen C.F., van der Gun J.W., Kreeftenberg J.G. Combined estimation of tetanus and diphtheria antitoxin in human sera by the in vitro Toxin-Binding Inhibition (ToBI) test. J Biol Stand 1989, 17(2):191-200.
15. Centrum voor Infectieziekten Bestrijding - RIVM. Uitvoeringsregels RVP 2010; 2010. p. 20.
16. De Melker H.E., van den H.S., Berbers G.A., Nagelkerke N.J., Rumke H.C., Conyn-Van Spaendonck M.A. A population-based study on tetanus antitoxin levels in the Netherlands. Vaccine 2000, 18(1-2):100-108.
17. Oostvogel P.M., van Wijngaarden J.K., van der Avoort H.G., et al. Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992-93. Lancet 1994, 344(8923):665-670.
18. van den Hof S., Conyn-Van Spaendonck M.A., Van Steenbergen J.E. Measles epidemic in the Netherlands, 1999-2000. J Infect Dis 2002, 186(10):1483-1486.
19. Karagiannis I., van Lier A., van Binnendijk R., et al. Mumps in a community with low vaccination coverage in the Netherlands. Euro Surveill 2008, 13(24).
20. Hahne S., Macey J., van Binnendijk R., et al. Rubella outbreak in the Netherlands, 2004-2005: high burden of congenital infection and spread to Canada. Pediatr Infect Dis. J 2009, 28(9):795-800.
21. Colombet I., Saguez C., Sanson-Le Pors M.J., Coudert B., Chatellier G., Espinoza P. Diagnosis of tetanus immunization status: multicenter assessment of a rapid biological test. Clin Diagn Lab Immunol 2005, 12(9):1057-1062.
22. Elkharrat D., Espinoza P., De la C.J., Potel G., Pourriat J.L., Sanson-Le Pors M.J. Inclusion of a rapid test in the current Health Ministry Guidelines with the purpose of improving anti-tetanus prophylaxis prescribed to wounded patients presenting at French Emergency Departments. Med Mal Infect 2005, 35(6):323-328.
23. Stubbe M., Mortelmans L.J., Desruelles D., et al. Improving tetanus prophylaxis in the emergency department: a prospective, double-blind cost-effectiveness study. Emerg Med J 2007, 24(9):648-653.
24. Gergen P.J., McQuillan G.M., Kiely M., Ezzati-Rice T.M., Sutter R.W., Virella G. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 1995, 332(12):761-766.
25. de Voer R.M., Mollema L., Schepp R.M., de Greeff S.C., van Gageldonk P.G., de Melker H.E., et al. Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine. PLoS One 2010, 5(8):e12144.